Merkel cell carcinoma: Improved outcome with the addition of adjuvant therapy [8]

Journal of Clinical Oncology

Volumn 23, Issue 28, 2005, Pages 7236-7237

  Wilson, Lynn D ^a   Housman, Douglas ^a   Smith, Benjamin D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FOLLOW UP; HUMAN; LETTER; MEDICAL DECISION MAKING; MERKEL CELL TUMOR; PRIORITY JOURNAL; TREATMENT FAILURE; ADJUVANT THERAPY; CLINICAL TRIAL; LYMPH NODE METASTASIS; NOTE; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; SKIN TUMOR; TUMOR RECURRENCE;

CARCINOMA, MERKEL CELL; CLINICAL TRIALS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SKIN NEOPLASMS;

EID: 27244442917     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.4430     Document Type: Letter

References (2)

1. Allen PJ, Browne WB, Jaques DP, et al: Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300-2309, 2005
2. Wilson LD, Gruber SB: Merkel cell carcinoma and the controversial role of adjuvant radiation therapy: Clinical choices in the absence of statistical evidence. J Am Acad Dermatol 50:435-437, 2004